CE Disclosure Information for DBT Skills

Last updated about 1 month ago

Disclaimers & Disclosures


DBT Skills Online Course

Information about the Instructor(s)

Marsha M. Linehan, PhD, ABPP
, the developer of Dialectical Behavior Therapy, is a Professor of Psychology and an adjunct Professor of   Psychiatry at the University of Washington. She is also the Director of the Behavioral Research and Therapy Clinics, where she conducts   research to develop and evaluate treatments for severe and complex mental disorders. She is the Founder of the Linehan Institute, Behavioral Tech, LLC, and Behavioral Tech Research. She has played a major role in the consultation, supervision, and training of mental health professionals around the world. DBT was celebrated by TIME in the book 100 New Scientific Discoveries. In 2016, the Association   for Behavioral and Cognitive Therapies honored Dr. Linehan with a Career/Lifetime Achievement award.
 
Faculty Disclosure Statement:

Marsha M. Linehan, PhD, ABPP
is the treatment developer of Dialectical Behavior Therapy (DBT).  She also receives royalties for her books on DBT and her research on DBT is funded by the US federal government.

Faculty Disclaimer: When an unlabelled use of a commercial product, or an investigative use not yet approved for any purpose is discussed during an educational activity, we shall require the speaker to disclose that the product is not labeled for the use under discussion or that the product is still investigative.
 
Notice of requirements for successful completion: For online training course, participants must complete the online course and all course materials to meet course completion requirements listed.

Commercial support or sponsorship: There is no commercial company support for this CME/CE event.
 
Noncommercial Sponsor Support: There is no noncommercial sponsor support for this CME/CE activity.
  
Off-Label Product Use: This CME/CE activity does not include any unannounced information about off-label use of a product for a purpose other than that for which it was approved by the Food and Drug Administration (FDA).